{"id":4692,"date":"2016-10-14T05:28:02","date_gmt":"2016-10-14T09:28:02","guid":{"rendered":"https:\/\/medicarereport.org\/?p=4692"},"modified":"2016-10-13T08:30:35","modified_gmt":"2016-10-13T12:30:35","slug":"a-big-alzheimers-drug-trial-now-wrapping-up-could-offer-real-hope-or-crush-it","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=4692","title":{"rendered":"A big Alzheimer\u2019s drug trial now wrapping up could offer real hope \u2014 or crush it"},"content":{"rendered":"<p>(By Damian Garde for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">S<\/span>cientists at Eli Lilly are racing to wrap up a clinical trial on a drug that could be the first major advance in treating Alzheimer\u2019s in more than a decade \u2014 or a crushing reminder of why the memory-destroying disease has <a href=\"https:\/\/www.statnews.com\/2016\/07\/28\/alzheimers-drug-failure\/\" target=\"_blank\">bedeviled researchers<\/a><sup class=\"footnote\">1<\/sup> for so long. <a href=\"https:\/\/www.statnews.com\/2016\/10\/13\/alzheimers-drug-eli-lilly\/\" target=\"_blank\">Continue reading article here&#8230;&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"stat-logo\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Damian Garde for STAT) Scientists at Eli Lilly are racing to wrap up a clinical trial on a drug<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18,17,15],"tags":[],"class_list":["post-4692","post","type-post","status-publish","format-standard","hentry","category-aging","category-emerging-health-issues","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4692"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4692\/revisions"}],"predecessor-version":[{"id":4693,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4692\/revisions\/4693"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}